Altrinsic Global Advisors LLC Cabaletta Bio, Inc. Transaction History

Altrinsic Global Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.68 - $3.92 $235,200 - $548,800	-140,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $67,200 - $292,800	20,000 Added 16.67%	140,000 $531,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $70,000 - $125,000	-10,000 Reduced 7.69%	120,000 $1.46 Million
Q2 2021 Aug 13, 2021	BUY	$7.2 - $11.73 $72,000 - $117,300	10,000 Added 8.33%	130,000 $1.12 Million
Q1 2021 May 14, 2021	BUY	$10.39 - $14.53 $207,800 - $290,600	20,000 Added 20.0%	120,000 $1.33 Million
Q2 2020 Aug 14, 2020	BUY	$6.39 - $11.28 $639,000 - $1.13 Million	100,000 New	100,000 $1.11 Million

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $87.9M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.